Trial intelligence / Profile preview

Linagliptin on Intestinal TRL Metabolism in Type 2 Diabetes

NCT02280174Phase 4Unknown

Sponsor
Ministerio de Salud
Start
Sep 2014
Primary completion
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Ministerio de Salud. Status: unknown.

02

Drugs

linagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02280174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02280174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call